Jing Qian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jing Qian has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Hongkai Shang
Department of Gynecology, Affiliated Hangzhou First People's Hospital, School of Medicine Westlake University Zhejiang Hangzhou China
1 shared publication- Hongkai Shang
Department of Gynecology, Affiliated Hangzhou First People’s Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang Province, China
1 shared publication - Huan Shi
The Fourth Clinical School of Medicine, Zhejiang Chinese Medical University, Hangzhou First People’s Hospital, Hangzhou, China
1 shared publication - Jie Yu
The Fourth Clinical School of Medicine, Zhejiang Chinese Medical University, Hangzhou First People’s Hospital, Hangzhou, China
1 shared publication Jing Qian
Zhejiang Univ, Sch Med, Hangzhou Peoples Hosp 1, Dept Obster, Hangzhou 310006, Zhejiang, Peoples R China
1 shared publication- Jun-Lei Lu
The Fourth Clinical School of Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China
1 shared publication
Latest Publications
- Open Access
- 17 June 2025
- Published by Springer Nature in Lasers in Medical Science
- Vol. 40 (1) , 1-10
A comparative study of 5-aminolevulinic acid photodynamic therapy and loop electrosurgical excision procedure in the treatment of cervical high grade squamous intraepithelial lesions
Purpose To compare the efficacy and safety of 5-Aminolevulinic Acid Photodynamic Therapy (5-ALA-PDT) and Loop Electrosurgical Excision Procedure (LEEP) in the treatment of cervical high grade squamous intraepithelial lesions (HSIL). Methods The data of 116 patients with pathologically diagnosed cervical HSIL in Hangzhou First People’s Hospital from January 2020 to June 2023 were retrospectively analyzed. According to the treatment methods, they were divided into 5-ALA-PDT group (50 cases) and LEEP group (66 cases). The patients were followed up at 3 months, 6 months, and 12 months after treatment. The clinical data of the two groups were compared. Results There were no significant differences in baseline data between the two groups of patients (P > 0.05). At 12-month follow-up the complete remission (CR) rate of LEEP group and 5-ALA-PDT group was 93.94% (62/66) and 86.00% (43/50) (P = 0.260), respectively. The HPV clearance rate of LEEP group and 5-ALA-PDT group was 66.67% (44/66) and 80.00% (40/50) (P = 0.112), respectively. Multivariate analysis revealed that endocervical canal involvement was a significant risk factor for 5-ALA-PDT failure (OR = 27.35, 95% CI: 3.512–43.390, P = 0.012) and persistent HPV infection (OR = 8.013, 95% CI: 2.045–36.901, P = 0.011). In terms of adverse reactions, most of the reactions in 5-ALA-PDT group were mild local reactions that could be relieved within one week. The proportion of bleeding and cervical scar formation was higher in patients in the LEEP group (P < 0.05). Conclusion 5-ALA-PDT and LEEP exhibit potential similarity in efficacy in the treatment of cervical HSIL, but the former has milder adverse reactions. The involvement of the endocervical canal is a significant risk factor for both 5-ALA-PDT failure and persistent HPV infection.
- 17 June 2025
- Published by Springer Nature in Lasers in Medical Science
- Vol. 40 (1) , 1-10
Open AccessA comparative study of 5-aminolevulinic acid photodynamic therapy and loop electrosurgical excision procedure in the treatment of cervical high grade squamous intraepithelial lesions
Purpose To compare the efficacy and safety of 5-Aminolevulinic Acid Photodynamic Therapy (5-ALA-PDT) and Loop Electrosurgical Excision Procedure (LEEP) in the treatment of cervical high grade squamous intraepithelial lesions (HSIL). Methods The data of 116 patients with pathologically diagnosed cervical HSIL in Hangzhou First People’s Hospital from January 2020 to June 2023 were retrospectively analyzed. According to the treatment methods, they were divided into 5-ALA-PDT group (50 cases) and LEEP group (66 cases). The patients were followed up at 3 months, 6 months, and 12 months after treatment. The clinical data of the two groups were compared. Results There were no significant differences in baseline data between the two groups of patients (P > 0.05). At 12-month follow-up the complete remission (CR) rate of LEEP group and 5-ALA-PDT group was 93.94% (62/66) and 86.00% (43/50) (P = 0.260), respectively. The HPV clearance rate of LEEP group and 5-ALA-PDT group was 66.67% (44/66) and 80.00% (40/50) (P = 0.112), respectively. Multivariate analysis revealed that endocervical canal involvement was a significant risk factor for 5-ALA-PDT failure (OR = 27.35, 95% CI: 3.512–43.390, P = 0.012) and persistent HPV infection (OR = 8.013, 95% CI: 2.045–36.901, P = 0.011). In terms of adverse reactions, most of the reactions in 5-ALA-PDT group were mild local reactions that could be relieved within one week. The proportion of bleeding and cervical scar formation was higher in patients in the LEEP group (P < 0.05). Conclusion 5-ALA-PDT and LEEP exhibit potential similarity in efficacy in the treatment of cervical HSIL, but the former has milder adverse reactions. The involvement of the endocervical canal is a significant risk factor for both 5-ALA-PDT failure and persistent HPV infection.
- 23 March 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (3) , e16277
Management of mid‐term abdominal pregnancy: A rare case report and literature review
Abdominal pregnancy (AP) is a rare form of ectopic pregnancy. It is associated with significant maternal and fetal risks, including high rates of morbidity and mortality. The condition poses considerable therapeutic challenges, particularly in the mid to late stages of gestation. To date, there is no standardized treatment protocol for such cases. We describe a case of a 37‐year‐old woman, G2P1, who was diagnosed with a live 16‐week AP. The patient underwent multidisciplinary treatment, including ultrasound‐guided methotrexate injection into the fetal heart, lauromacrogol injection into the placenta, oral administration of mifepristone, and subsequent laparotomy to remove the fetus, placenta, and left fallopian tube. This approach successfully demised the fetus, reduced the placental blood supply, and created more favorable conditions for surgery. The patient recovered uneventfully post‐surgery. This case illustrates the potential benefits of a combined therapeutic approach in successfully managing mid‐term AP.
- 23 March 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (3) , e16277
Management of mid‐term abdominal pregnancy: A rare case report and literature review
Abdominal pregnancy (AP) is a rare form of ectopic pregnancy. It is associated with significant maternal and fetal risks, including high rates of morbidity and mortality. The condition poses considerable therapeutic challenges, particularly in the mid to late stages of gestation. To date, there is no standardized treatment protocol for such cases. We describe a case of a 37‐year‐old woman, G2P1, who was diagnosed with a live 16‐week AP. The patient underwent multidisciplinary treatment, including ultrasound‐guided methotrexate injection into the fetal heart, lauromacrogol injection into the placenta, oral administration of mifepristone, and subsequent laparotomy to remove the fetus, placenta, and left fallopian tube. This approach successfully demised the fetus, reduced the placental blood supply, and created more favorable conditions for surgery. The patient recovered uneventfully post‐surgery. This case illustrates the potential benefits of a combined therapeutic approach in successfully managing mid‐term AP.
- Open Access
- 6 July 2020
- Published by Knowledge E DMCC in Iranian Journal of Public Health
- Vol. 49 (7) , 1376-1377
Bombay Blood Group and Pregnancy
- 6 July 2020
- Published by Knowledge E DMCC in Iranian Journal of Public Health
- Vol. 49 (7) , 1376-1377
Open AccessBombay Blood Group and Pregnancy
- Open Access
- 5 December 2019
- Published by Wiley in Case Reports in Obstetrics and Gynecology
- Vol. 2019, 1-4
Leiomyomatosis Peritonealis Disseminata with Sarcomatous Transformation: A Rare Case Report and Literature Review
Leiomyomatosis Peritonealis Disseminata (LPD) is an uncommon disease characterized by presence of Multiple Leiomyomas in the abdominal and pelvic cavity. Increasingly, literature supports that LPD is an iatrogenic condition. Malignant transformation of LPD is rarely reported. We hereby report a case of a middle-aged female patient who was diagnosed with malignant sarcomatous degeneration in LPD. Gynecologists may get inspiration from this case report.
- 5 December 2019
- Published by Wiley in Case Reports in Obstetrics and Gynecology
- Vol. 2019, 1-4
Open AccessLeiomyomatosis Peritonealis Disseminata with Sarcomatous Transformation: A Rare Case Report and Literature Review
Leiomyomatosis Peritonealis Disseminata (LPD) is an uncommon disease characterized by presence of Multiple Leiomyomas in the abdominal and pelvic cavity. Increasingly, literature supports that LPD is an iatrogenic condition. Malignant transformation of LPD is rarely reported. We hereby report a case of a middle-aged female patient who was diagnosed with malignant sarcomatous degeneration in LPD. Gynecologists may get inspiration from this case report.